社区
首页
集团介绍
社区
资讯
行情
学堂
TigerAI
登录
注册
小冬_1637
IP属地:福建
+关注
帖子 · 39
帖子 · 39
关注 · 0
关注 · 0
粉丝 · 0
粉丝 · 0
小冬_1637
小冬_1637
·
05-28
什么假新闻 笑死
异动解读 | GLP-1赛道新星派格生物医药-B盘中大涨5.36%,投资者看好其商业化前景
港股上市第二日,派格生物医药-B今日盘中大涨5.36%,引发市场广泛关注。这家专注于自主研发慢性病创新疗法的生物技术公司,正吸引着投资者的目光。派格生物医药于5月27日在港交所成功上市,发行价为15.6港元/股。其核心产品PB-119是一款每周一次的长效GLP-1激动剂,已完成III期试验并在2023年提交国内上市申请,预计将于2025年获得NDA批准并在中国商业化推出。
异动解读 | GLP-1赛道新星派格生物医药-B盘中大涨5.36%,投资者看好其商业化前景
看
180
回复
评论
点赞
2
编组 21备份 2
分享
举报
小冬_1637
小冬_1637
·
05-27
$派格生物医药-B(02565)$
还能起的来吗,昨天没时间盯盘,亏300没卖,现在要亏3千了,干
看
453
回复
评论
点赞
1
编组 21备份 2
分享
举报
小冬_1637
小冬_1637
·
04-17
看时间浪费的
看
500
回复
评论
点赞
点赞
编组 21备份 2
分享
举报
小冬_1637
小冬_1637
·
04-17
$霸王茶姬(CHA)$
400中5 打了3次都中 但也太少了 赚这几块钱 还要熬夜 玛德
看
384
回复
评论
点赞
点赞
编组 21备份 2
分享
举报
小冬_1637
小冬_1637
·
04-17
$霸王茶姬(CHA)$
什么时候公布认购结果呀,正常是几点,有大神知道吗
看
1,692
回复
1
点赞
1
编组 21备份 2
分享
举报
小冬_1637
小冬_1637
·
04-15
当时蜜雪没中,哭晕了
看
245
回复
评论
点赞
点赞
编组 21备份 2
分享
举报
小冬_1637
小冬_1637
·
02-22
你是第一次打新吗?
看
1,282
回复
1
点赞
1
编组 21备份 2
分享
举报
小冬_1637
小冬_1637
·
02-14
$高途(GOTU)$
阿东啊,我一卖你就涨,我一买你就跌,不能这样对我呀
看
1,688
回复
1
点赞
2
编组 21备份 2
分享
举报
小冬_1637
小冬_1637
·
02-06
$古茗(01364)$
怎么没人讨论 不好买
看
937
回复
评论
点赞
点赞
编组 21备份 2
分享
举报
小冬_1637
小冬_1637
·
01-07
$高途(GOTU)$
还能涨吗
看
861
回复
评论
点赞
2
编组 21备份 2
分享
举报
加载更多
暂无粉丝
热议股票
{"i18n":{"language":"zh_CN"},"isCurrentUser":false,"userPageInfo":{"id":"3550727663913398","uuid":"3550727663913398","gmtCreate":1587633641417,"gmtModify":1587633659577,"name":"小冬_1637","pinyin":"xd1637xiaodong1637","introduction":"","introductionEn":"","signature":"","avatar":"https://static.tigerbbs.com/4b64af62063a80ff7e942af8ee0b610a","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":2,"headSize":10,"tweetSize":39,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":2,"name":"无畏虎","nameTw":"無畏虎","represent":"初生牛犊","factor":"发布3条非转发主帖,1条获得他人回复或点赞","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":1,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-3","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"偶像虎友","description":"加入老虎社区1500天","bigImgUrl":"https://static.tigerbbs.com/8b40ae7da5bf081a1c84df14bf9e6367","smallImgUrl":"https://static.tigerbbs.com/f160eceddd7c284a8e1136557615cfad","grayImgUrl":"https://static.tigerbbs.com/11792805c468334a9b31c39f95a41c6a","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2024.06.02","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","templateUuid":"518b5610c3e8410da5cfad115e4b0f5a","name":"实盘交易者","description":"完成一笔实盘交易","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":2,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":3,"crmLevelSwitch":0,"location":"福建","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":1,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"page":1,"watchlist":null,"tweetList":[{"id":439785522270408,"gmtCreate":1748397904575,"gmtModify":1748397905787,"author":{"id":"3550727663913398","authorId":"3550727663913398","name":"小冬_1637","avatar":"https://static.tigerbbs.com/4b64af62063a80ff7e942af8ee0b610a","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3550727663913398","authorIdStr":"3550727663913398"},"themes":[],"htmlText":"什么假新闻 笑死","listText":"什么假新闻 笑死","text":"什么假新闻 笑死","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/439785522270408","repostId":"1113728130","repostType":2,"repost":{"id":"1113728130","kind":"news","weMediaInfo":{"introduction":"个股异动一手消息解读","home_visible":1,"media_name":"异动解读","id":"1092702339","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"pubTimestamp":1748396118,"share":"https://www.laohu8.com/m/news/1113728130?lang=&edition=full","pubTime":"2025-05-28 09:35","market":"hk","language":"zh","title":"异动解读 | GLP-1赛道新星派格生物医药-B盘中大涨5.36%,投资者看好其商业化前景","url":"https://stock-news.laohu8.com/highlight/detail?id=1113728130","media":"异动解读","summary":"港股上市第二日,派格生物医药-B今日盘中大涨5.36%,引发市场广泛关注。这家专注于自主研发慢性病创新疗法的生物技术公司,正吸引着投资者的目光。派格生物医药于5月27日在港交所成功上市,发行价为15.6港元/股。其核心产品PB-119是一款每周一次的长效GLP-1激动剂,已完成III期试验并在2023年提交国内上市申请,预计将于2025年获得NDA批准并在中国商业化推出。","content":"<p>港股上市第二日,派格生物医药-B(02565)今日盘中大涨5.36%,引发市场广泛关注。这家专注于自主研发慢性病创新疗法的生物技术公司,正吸引着投资者的目光。</p>\n\n<p>派格生物医药于5月27日在港交所成功上市,发行价为15.6港元/股。公司聚焦代谢紊乱相关疾病领域,重点布局包括2型糖尿病、肥胖症、非酒精性脂肪性肝炎等多个慢性代谢性疾病治疗方向。其核心产品PB-119是一款每周一次的长效GLP-1激动剂,已完成III期试验并在2023年提交国内上市申请,预计将于2025年获得NDA批准并在中国商业化推出。</p>\n\n<p>分析人士指出,派格生物医药-B股价的强劲表现,主要得益于以下几个因素:首先,GLP-1赛道备受市场关注,随着肥胖症和糖尿病患者数量持续增加,该领域的市场潜力巨大;其次,公司核心产品PB-119已进入商业化冲刺阶段,有望为公司带来可观收入;最后,近期监管层对未盈利企业上市表示支持,医药IPO热潮正在回暖,这为像派格生物这样的创新生物科技企业提供了有利的融资环境。</p>","source":"ai_movement_cn","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>异动解读 | GLP-1赛道新星派格生物医药-B盘中大涨5.36%,投资者看好其商业化前景</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n异动解读 | GLP-1赛道新星派格生物医药-B盘中大涨5.36%,投资者看好其商业化前景\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092702339\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">异动解读 </p>\n<p class=\"h-time\">2025-05-28 09:35</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>港股上市第二日,派格生物医药-B(02565)今日盘中大涨5.36%,引发市场广泛关注。这家专注于自主研发慢性病创新疗法的生物技术公司,正吸引着投资者的目光。</p>\n\n<p>派格生物医药于5月27日在港交所成功上市,发行价为15.6港元/股。公司聚焦代谢紊乱相关疾病领域,重点布局包括2型糖尿病、肥胖症、非酒精性脂肪性肝炎等多个慢性代谢性疾病治疗方向。其核心产品PB-119是一款每周一次的长效GLP-1激动剂,已完成III期试验并在2023年提交国内上市申请,预计将于2025年获得NDA批准并在中国商业化推出。</p>\n\n<p>分析人士指出,派格生物医药-B股价的强劲表现,主要得益于以下几个因素:首先,GLP-1赛道备受市场关注,随着肥胖症和糖尿病患者数量持续增加,该领域的市场潜力巨大;其次,公司核心产品PB-119已进入商业化冲刺阶段,有望为公司带来可观收入;最后,近期监管层对未盈利企业上市表示支持,医药IPO热潮正在回暖,这为像派格生物这样的创新生物科技企业提供了有利的融资环境。</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"","is_english":false,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1113728130","content_text":"港股上市第二日,派格生物医药-B(02565)今日盘中大涨5.36%,引发市场广泛关注。这家专注于自主研发慢性病创新疗法的生物技术公司,正吸引着投资者的目光。\n派格生物医药于5月27日在港交所成功上市,发行价为15.6港元/股。公司聚焦代谢紊乱相关疾病领域,重点布局包括2型糖尿病、肥胖症、非酒精性脂肪性肝炎等多个慢性代谢性疾病治疗方向。其核心产品PB-119是一款每周一次的长效GLP-1激动剂,已完成III期试验并在2023年提交国内上市申请,预计将于2025年获得NDA批准并在中国商业化推出。\n分析人士指出,派格生物医药-B股价的强劲表现,主要得益于以下几个因素:首先,GLP-1赛道备受市场关注,随着肥胖症和糖尿病患者数量持续增加,该领域的市场潜力巨大;其次,公司核心产品PB-119已进入商业化冲刺阶段,有望为公司带来可观收入;最后,近期监管层对未盈利企业上市表示支持,医药IPO热潮正在回暖,这为像派格生物这样的创新生物科技企业提供了有利的融资环境。","news_type":1,"symbols_score_info":{"02565":1}},"isVote":1,"tweetType":1,"viewCount":180,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":439554027524648,"gmtCreate":1748341767060,"gmtModify":1748341768448,"author":{"id":"3550727663913398","authorId":"3550727663913398","name":"小冬_1637","avatar":"https://static.tigerbbs.com/4b64af62063a80ff7e942af8ee0b610a","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3550727663913398","authorIdStr":"3550727663913398"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/02565\">$派格生物医药-B(02565)$ </a> 还能起的来吗,昨天没时间盯盘,亏300没卖,现在要亏3千了,干","listText":"<a href=\"https://laohu8.com/S/02565\">$派格生物医药-B(02565)$ </a> 还能起的来吗,昨天没时间盯盘,亏300没卖,现在要亏3千了,干","text":"$派格生物医药-B(02565)$ 还能起的来吗,昨天没时间盯盘,亏300没卖,现在要亏3千了,干","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/439554027524648","isVote":1,"tweetType":1,"viewCount":453,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":425555126567248,"gmtCreate":1744905274640,"gmtModify":1744905277661,"author":{"id":"3550727663913398","authorId":"3550727663913398","name":"小冬_1637","avatar":"https://static.tigerbbs.com/4b64af62063a80ff7e942af8ee0b610a","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3550727663913398","authorIdStr":"3550727663913398"},"themes":[],"htmlText":"看时间浪费的","listText":"看时间浪费的","text":"看时间浪费的","images":[{"img":"https://static.tigerbbs.com/6bb4724a3d8d90d52af459d5ec701efb","width":"1080","height":"1920"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/425555126567248","isVote":1,"tweetType":1,"viewCount":500,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":425545399333344,"gmtCreate":1744902743402,"gmtModify":1744902775977,"author":{"id":"3550727663913398","authorId":"3550727663913398","name":"小冬_1637","avatar":"https://static.tigerbbs.com/4b64af62063a80ff7e942af8ee0b610a","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3550727663913398","authorIdStr":"3550727663913398"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/CHA\">$霸王茶姬(CHA)$ </a> 400中5 打了3次都中 但也太少了 赚这几块钱 还要熬夜 玛德","listText":"<a href=\"https://laohu8.com/S/CHA\">$霸王茶姬(CHA)$ </a> 400中5 打了3次都中 但也太少了 赚这几块钱 还要熬夜 玛德","text":"$霸王茶姬(CHA)$ 400中5 打了3次都中 但也太少了 赚这几块钱 还要熬夜 玛德","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/425545399333344","isVote":1,"tweetType":1,"viewCount":384,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":425537746072184,"gmtCreate":1744900930805,"gmtModify":1744900932227,"author":{"id":"3550727663913398","authorId":"3550727663913398","name":"小冬_1637","avatar":"https://static.tigerbbs.com/4b64af62063a80ff7e942af8ee0b610a","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3550727663913398","authorIdStr":"3550727663913398"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/CHA\">$霸王茶姬(CHA)$ </a> 什么时候公布认购结果呀,正常是几点,有大神知道吗","listText":"<a href=\"https://laohu8.com/S/CHA\">$霸王茶姬(CHA)$ </a> 什么时候公布认购结果呀,正常是几点,有大神知道吗","text":"$霸王茶姬(CHA)$ 什么时候公布认购结果呀,正常是几点,有大神知道吗","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/425537746072184","isVote":1,"tweetType":1,"viewCount":1692,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"4207171345955212","authorId":"4207171345955212","name":"不知道叫什么名字好","avatar":"https://static.tigerbbs.com/6aaac16a077368575ce231f3b11de068","crmLevel":5,"crmLevelSwitch":0,"idStr":"4207171345955212","authorIdStr":"4207171345955212"},"content":"今晚别睡觉就对了[得意]","text":"今晚别睡觉就对了[得意]","html":"今晚别睡觉就对了[得意]"}],"imageCount":0,"langContent":"CN","totalScore":0},{"id":424679301689888,"gmtCreate":1744690288984,"gmtModify":1744690291478,"author":{"id":"3550727663913398","authorId":"3550727663913398","name":"小冬_1637","avatar":"https://static.tigerbbs.com/4b64af62063a80ff7e942af8ee0b610a","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3550727663913398","authorIdStr":"3550727663913398"},"themes":[],"htmlText":"当时蜜雪没中,哭晕了","listText":"当时蜜雪没中,哭晕了","text":"当时蜜雪没中,哭晕了","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/424679301689888","isVote":1,"tweetType":1,"viewCount":245,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":406217033851504,"gmtCreate":1740201137252,"gmtModify":1740201139306,"author":{"id":"3550727663913398","authorId":"3550727663913398","name":"小冬_1637","avatar":"https://static.tigerbbs.com/4b64af62063a80ff7e942af8ee0b610a","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3550727663913398","authorIdStr":"3550727663913398"},"themes":[],"htmlText":"你是第一次打新吗?","listText":"你是第一次打新吗?","text":"你是第一次打新吗?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/406217033851504","isVote":1,"tweetType":1,"viewCount":1282,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":403495788102256,"gmtCreate":1739534688823,"gmtModify":1739534690264,"author":{"id":"3550727663913398","authorId":"3550727663913398","name":"小冬_1637","avatar":"https://static.tigerbbs.com/4b64af62063a80ff7e942af8ee0b610a","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3550727663913398","authorIdStr":"3550727663913398"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/GOTU\">$高途(GOTU)$ </a> 阿东啊,我一卖你就涨,我一买你就跌,不能这样对我呀","listText":"<a href=\"https://laohu8.com/S/GOTU\">$高途(GOTU)$ </a> 阿东啊,我一卖你就涨,我一买你就跌,不能这样对我呀","text":"$高途(GOTU)$ 阿东啊,我一卖你就涨,我一买你就跌,不能这样对我呀","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/403495788102256","isVote":1,"tweetType":1,"viewCount":1688,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":400779373158912,"gmtCreate":1738853841407,"gmtModify":1738853842831,"author":{"id":"3550727663913398","authorId":"3550727663913398","name":"小冬_1637","avatar":"https://static.tigerbbs.com/4b64af62063a80ff7e942af8ee0b610a","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3550727663913398","authorIdStr":"3550727663913398"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/01364\">$古茗(01364)$ </a> 怎么没人讨论 不好买","listText":"<a href=\"https://laohu8.com/S/01364\">$古茗(01364)$ </a> 怎么没人讨论 不好买","text":"$古茗(01364)$ 怎么没人讨论 不好买","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/400779373158912","isVote":1,"tweetType":1,"viewCount":937,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":389795296141736,"gmtCreate":1736209524118,"gmtModify":1736209525381,"author":{"id":"3550727663913398","authorId":"3550727663913398","name":"小冬_1637","avatar":"https://static.tigerbbs.com/4b64af62063a80ff7e942af8ee0b610a","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3550727663913398","authorIdStr":"3550727663913398"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/GOTU\">$高途(GOTU)$ </a> 还能涨吗","listText":"<a href=\"https://laohu8.com/S/GOTU\">$高途(GOTU)$ </a> 还能涨吗","text":"$高途(GOTU)$ 还能涨吗","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/389795296141736","isVote":1,"tweetType":1,"viewCount":861,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0}],"defaultTab":"followers","isTTM":false}